This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Kate learned about topical steroid withdrawal when her son Alex stopped growing, and she took him off his eczema cream. Alexs eczema, also known as atopic dermatitis, began in infancy with small, itchy patches on his wrists and handsa condition Kate, a seasoned nurse, was familiar with. After six months, his eczema was completely gone.
King has practiced as a dermatology provider since 2016. The Okmulgee office will offer comprehensive care for a wide range of dermatologic conditions for patients of all ages, including acne, psoriasis, eczema, and skin cancer.
In dermatology, and other fields, programmers have developed convoluted neural networks (CNN), where multiple hidden layers allow for the technology to learn different ways to interpret the data. Dermatologist-level classification of skin cancer with deep neural networks. 2018 PubMed Esteva A, Kuprel B, Novoa RA, et al.
Royalactin-Like Protein Inhibits Embryonic Stem Cells Mammals do not produce the royalactin protein, yet the royalactin activated a network of genes known to code proteins that allow the embryonic stem cells to maintain their pluripotency. What they discovered is that royalactin performed the same function. The question is: How?
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content